Over the past several decades, the United States has made little progress in improving the overall rate of survival from
The risk of stroke and bleeding in atrial fibrillation is currently estimated by clinical risk factors, for example, the CHA 2 DS 2 -VASc and HAS-BLED scores. The clinical risk factors for stroke and major bleeding overlap to a large extent and, therefore, provide limited guidance for tailoring of anticoagulant treatment. Recently, cardiac troponin and N-terminal probrain natriuretic peptide were shown to contribute independent information on the risk of stroke and mortality in patients with atrial fibrillation. In this biomarker substudy of 14 798 patients with atrial fibrillation randomized to oral anticoagulation with either apixaban or warfarin during a median time of 1.9 years, we evaluated the prognostic value of growth differentiation factor 15 (GDF-15), a marker of oxidative stress and inflammation, alone and in addition to clinical characteristics. The results showed that a higher level of GDF-15 was associated with a higher risk of all cardiovascular outcomes, that is, stroke, total and cardiac mortality, myocardial infarction, and major bleeding. After adjustment for all baseline characteristics, comorbidities, and other biomarkers, the GDF-15 level remained an independent risk indicator for major bleeding and death. Thus, GDF-15 seems to be a biomarker improving risk stratification for bleeding and mortality beyond clinical risk factors and other biomarkers in anticoagulated patients with atrial fibrillation. The benefits of apixaban compared with warfarin in terms of stroke, mortality, and major bleeding were consistent, regardless of the GDF-15 levels. The addition of GDF-15 to clinical risk stratification models has the potential to improve risk assessment of bleeding and mortality during anticoagulant treatment. See p 1847.
Temporal Trends in Coverage of Historical Cardiac Arrests Using a Volunteer-Based Network of Automated External Defibrillators Accessible to Laypersons and Emergency Dispatch Centers
Out-of-hospital cardiac arrest is a major public health concern associated with a poor prognosis. Automated external defibrillators (AEDs) can markedly increase survival, and can be safely and effectively used by laypersons. Although AEDs have been widely disseminated in community settings, they are often privately owned or deployed as a result of local political initiatives, with no underlying strategy in terms of covering high-risk sites of cardiac arrest or linkage to the emergency medical services. Our study describes the organization and 5-year follow-up of a unique nationwide volunteer-based AED network linked to all emergency dispatch centers, with continuously updated and validated information regarding AED viability, location, and accessibility. The study demonstrates how the AED network can be used to monitor AED availability, and thus identify areas for targeted AED deployment by authorities, and to guide bystanders to the nearest AED in case of cardiac arrest. The 5-year follow-up period showed that, although unguided AED deployment markedly increased the coverage of cardiac arrests, most AEDs were placed in areas with no or low incidence of cardiac arrests. This strongly speaks to the importance of a strategic effort to provide coverage of high-risk areas of cardiac arrest. The results provide insight into how unguided AED dissemination affects the coverage of public cardiac arrests as well as how an AED network can serve as a guide for communities seeking to optimize AED placement and use to improve survival after out-of-hospital cardiac arrest. See p 1859.
Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External Defibrillators
Out-of-hospital cardiac arrest (OHCA) is a leading cause of death in industrialized countries. Interventions aimed at improved bystander cardiopulmonary resuscitation and earlier defibrillation have been implemented in several communities to increase survival rates after OHCA. In The Netherlands, national initiatives were primarily focused on decreasing time to first shock by more widespread use of the automated external defibrillator (AED) by dispatched rescuers (firefighter/police team) and by layperson rescuers using publicly available AEDs. We aimed to establish whether survival with favorable neurologic outcome after OHCA has significantly increased over time, and, if so, whether this is attributable to AED use. We performed a population-based cohort study in The Netherlands, including patients with OHCA from cardiac causes between 2006 and 2012, excluding emergency medical service-witnessed arrests. Survival rates with favorable neurologic outcome after OHCA increased (16.2% to 19.7%; P for trend=0.021), although only in patients presenting with a shockable rhythm (29.1% to 41.4%; P for trend<0.001). Survival rates increased at each stage of the resuscitation process; the strongest increase occurred in the prehospital phase. The proportion of surviving patients with favorable neurologic outcome remained high throughout the study period (89.9% to 95.1%). Rates of AED use almost tripled during the study period (21.4% to 59.3%; P for trend<0.001), thereby decreasing time from emergency call to defibrillation device connection (median, 9.9 to 8.0 minutes; P<0.001), resulting in an increased proportion of delivered shocks that were <6 minutes (9.2% to 21.7%; P<0.001). Increased AED use is associated with increased survival in patients with a shockable initial rhythm. We recommend continuous efforts to improve resuscitation care, with strong emphasis on introducing or extending AED programs, and involving both dispatched AEDs and onsite AEDs. See p 1868.
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November 18, 2014 out-of-hospital cardiac arrest, with survival rates remaining relatively unchanged at 7.6%. In recent years, advances in resuscitation science and a renewed focus on early delivery of high-quality cardiopulmonary resuscitation (CPR) offered hope for improvements in survival. In this article by Chan and colleagues, the authors leveraged contemporary data from a large, prospective U.S. registry for out-of-hospital cardiac arrest and examined whether survival for this condition has indeed increased. The authors found that rates of overall survival (ie, to hospital discharge) for out-of-hospital cardiac arrest between 2005 and 2012 have increased by ≈50%, and these gains were attributable to both improvements in prehospital and in-hospital survival. Among those surviving to hospital discharge, the authors also found that there was a temporal trend for less severe neurological disability. Rates of bystander CPR and use of automated external defibrillators modestly increased during this study period and, in part, accounted for the gains in prehospital survival. Collectively, these findings indicate that the dismal rates of out-of-hospital cardiac arrest survival that have persisted for so long in the United States are not immutable, and they suggest the possibility of achieving further gains in survival. See p 1876.
Trends in Short-and Long-Term Survival Among Out-of-Hospital Cardiac Arrest Patients Alive at Hospital Arrival
Out-of-hospital cardiac arrest (OHCA) is associated with a poor prognosis and poses a significant burden to the healthcare system. However, few studies have evaluated whether OHCA incidence and survival have changed over time. We performed an observational study using a population-based cohort study including 34 291 OHCA patients who were transported alive to an acute-care hospital from 2002 to 2012 in Ontario. Over this time period, OHCA patients were increasingly more likely to have cardiovascular risk factors but less likely to have previous cardiovascular conditions. The overall incidence of OHCA patients transported to the hospital alive did not change over the past decade. Short-and longer-term survival after OHCA has substantially improved, with younger patients experiencing the greatest improvement. See p 1883.
